Controlled Movement Method for Gametes, Zygotes, Embryos
Summary
USPTO published patent application US20260098250A1 assigned to CIC nanoGUNE, filed September 6, 2023, covering a method and device for controlled movement of gametes, zygotes, and embryos using micro-scale carriers. The device comprises biocompatible carriers with maximum 500 μm dimensions that can releasably connect to biological cells and move autonomously or via external influences. The technology aims to enable less invasive procedures and higher implantation rates in reproductive medicine and healthcare applications.
What changed
USPTO published patent application US20260098250A1 for a method and device enabling controlled movement of gametes, zygotes, and embryos through releasable connection to micro-scale carriers composed of biocompatible materials. The carriers have maximum dimensions of 500 μm in all spatial directions and can move autonomously or be directed by external influences. The disclosed applications include in vivo reproduction and healthcare, with claimed benefits of reduced invasiveness and improved implantation rates.
For parties in biotechnology, reproductive medicine, and medical device sectors, this published application represents publicly available prior art and potential competitive landscape intelligence. No immediate compliance obligations arise from this publication. The application remains subject to USPTO examination and may be rejected, require amendment, or issue as a granted patent, which would establish binding IP rights upon issuance.
What to do next
- Monitor for patent grant or examination requests
Archived snapshot
Apr 14, 2026GovPing captured this document from the original source. If the source has since changed or been removed, this is the text as it existed at that time.
METHOD AND DEVICE AT LEAST FOR THE CONTROLLED MOVEMENT OF GAMETES AND/OR ZYGOTES AND/OR EMBRYOS IN FLUIDS
Application US20260098250A1 Kind: A1 Apr 09, 2026
Assignee
ASOCIACIÓN CENTRO DE INVESTIGACIÓN COOPERATIVA EN NANOCIENCIAS "CIC NANOGUNE"
Inventors
Mariana MEDINA-SÁNCHEZ
Abstract
A method, as can be applied, for example, in in vivo reproduction and in healthcare, and to a device for realizing the controlled movement. The device can be used in a considerably less invasive manner and significantly higher implantation rates can be realized using the method. By the method, gametes and/or zygotes and/or embryos are releasably connected to one or more carriers, and the carriers, with or without gametes and/or zygotes and/or embryos, are moved in a directed manner autonomously or by external influences. The device includes at least one carrier having maximum dimensions in all spatial directions of 500 μm, which carrier is composed at least primarily of biocompatible materials.
CPC Classifications
C12N 13/00
Filing Date
2023-09-06
Application No.
19109850
Related changes
Get daily alerts for USPTO Patent Applications - Biotech (C12N)
Daily digest delivered to your inbox.
Free. Unsubscribe anytime.
Source
About this page
Every important government, regulator, and court update from around the world. One place. Real-time. Free. Our mission
Source document text, dates, docket IDs, and authority are extracted directly from USPTO.
The summary, classification, recommended actions, deadlines, and penalty information are AI-generated from the original text and may contain errors. Always verify against the source document.
Classification
Who this affects
Taxonomy
Browse Categories
Get alerts for this source
We'll email you when USPTO Patent Applications - Biotech (C12N) publishes new changes.
Subscribed!
Optional. Filters your digest to exactly the updates that matter to you.